← All indications
Percutaneous Coronary Intervention
A family of percutaneous techniques that are used to manage CORONARY OCCLUSION, including standard balloon angioplasty (PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY), the placement of intracoronary STENTS, and atheroablative technologies (e.g., ATHERECTOMY; ENDARTERECTOMY; THROMBECTOMY; PERCUTANEOUS TRANSLUMINAL LASER ANGIOPLASTY). PTCA was the dominant form of PCI, before the widespread use of stenting.
Subtype terms (2)
More specific conditions that are subtypes of Percutaneous Coronary Intervention in the MeSH hierarchy.
- Angioplasty, Balloon, Coronary
19 drugs (17 approved, 2 experimental)
- Atherectomy, Coronary
Drugs by status
Approved for this indication (1)
Phase 4 trials (35)
- nitroglycerin
- heparin
- berberine
- dabigatran
- diltiazem
- empagliflozin
- rosuvastatin
- adenosine
- iopamidol
- pitavastatin
- atorvastatin
- colchicine
- ticagrelor
- prasugrel
- sitagliptin
- acetylsalicylic acid
- alteplase
- tranilast
- enoxaparin
- verapamil
- inclisiran
- fentanyl
- metoprolol
- bivalirudin
- cilostazol
- pioglitazone
- sufonylurea
- clopidogrel
- dapagliflozin
- sodium chloride
- +5 more
Phase 3 trials (10)
Phase 1 trials (1)
Other trials (5)